alexa Pharmacogenomics-innovations| OMICS International | Journal Of Bioequivalence And Bioavailability

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Pharmacogenomics Innovations

Pharmacogenomics is the research of how genes influence a person’s reaction to drugs. This comparatively new area brings together pharmacology and genomics to create efficient, safe drugs and doses that will be customized to a person’s genetic make-up. Innovations are new idea, device or process. Innovations are the application of better solutions that meet new requirements, inarticulated needs or existing market needs. It is proficient through more effective products, processes, services, technologies, or new ideas that are readily available to markets, governments and society. Innovations are something original and novel, as a significant, new that “breaks into” the market or society.
 
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
Last date updated on September, 2014